Ask AI
H.R. 2244

Patient Experience in Research Act of 2017

Patient Experience in Research Act of 2017

This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.

Referred to the Subcommittee on Health.

Rep. Lance, Leonard [R-NJ-7](R-NJ)Sponsor
3 cosponsors3 D
3cosponsors1committees4actions4subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Patient Experience in Research Act of 2017 — Informed